THOUSAND OAKS, Calif. (AP) — THOUSAND OAKS, Calif. (AP) — Atara Biotherapeutics Inc. (ATRA) on Thursday reported first-quarter net income of $38 million, after reporting a loss in the same period a year earlier.
The Thousand Oaks, California-based company said it had profit of $3.50 per share.
The drug developer posted revenue of $98.1 million in the period.
Atara Biotherapeutics shares have declined 50% since the beginning of the year. The stock has decreased 56% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ATRA at https://www.zacks.com/ap/ATRA